XNAS: INKT
MiNK Therapeutics Inc Live Stock Price Today, Share Analysis and Chart
about
MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering the discovery, development and manufacturing of allogeneic, off-the-shelf, invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated disea...
Read More
10.96
0.19
(1.76%)
5,985.2
XNAS Volume
XNAS 21 Jul, 2026 12:09 PM (EDT)
Not Eligible
Expensive Valuation
Technically Bearish
MiNK Therapeutics Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..